Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学ADC Lineage Targets

Giuseppe Curigliano

MD, PhD

🏢University of Milan and European Institute of Oncology🌐Italy

Professor of Medical Oncology

95
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Giuseppe Curigliano is a global leader in breast cancer clinical research and ADC development. He has contributed to key trials defining the role of HER2 targeting ADCs across HER2 positive and HER2 low disease. His work informs treatment sequencing and safety management of lineage targeting ADCs.

Share:

🧪Research Fields 研究领域

antibody drug conjugates
breast cancer
HER2 low
cardio oncology
clinical trials

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Giuseppe Curigliano 的研究动态

Follow Giuseppe Curigliano's research updates

留下邮箱,当我们发布与 Giuseppe Curigliano(University of Milan and European Institute of Oncology)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment